JR11 - Oral communication - David BRENNER

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the role of NEK1 in ALS, particularly highlighting the functional consequences of a missense variant. The argumentation is solid, supported by multiple experimental approaches including iPSC-derived motor neurons, protein expression analysis, and kinase activity assays. The data convincingly show that the missense variant impairs kinase function and leads to ALS-related phenotypes. The discussion on incomplete penetrance and the potential for functional testing to classify VUS adds practical value. However, the sample size is limited to one family, and the study is not yet peer-reviewed, which tempers the strength of the conclusions.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, with clear methodology and controls. The title accurately reflects the content. The sources cited are primarily the presenter’s own data and known literature on NEK1 and ALS. The Q&A session addresses potential limitations and alternative interpretations. The study builds on prior work from Jenna Gregory’s lab on TDP-43 pathology in NEK1 ALS. The lack of published references in the description limits external verification, but the internal consistency and use of established techniques support the reliability.

Title accurately reflects the content: an oral communication on ALS research.

8/10

Presentation of original research with functional validation, but limited peer review and small sample size.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of ALS genetics in Germany
• 02:00Identification of the PM598S missense variant in NEK1
• 05:00Conservation analysis and enrichment in ALS cohorts
• 08:00Autopsy findings: TDP-43 and P62 pathology
• 10:00iPSC-derived motor neuron experiments: axonal pathology and apoptosis
• 12:00DNA damage and cilia phenotypes
• 14:00Kinase activity assays and rescue experiments
• 16:00Omics analysis and summary of findings
• 18:00Discussion on penetrance and risk factors
• 20:00Q&A session on variant classification and future directions

• German ALS network (MND-NET) — Cohort used for burden analysis
• Project MinE — Cohort used for burden analysis
• gnomAD — Reference population database for variant frequency

• Jenna Gregory's lab on NEK1 ALS and TDP-43 pathology — Prior work showing TDP-43 pathology in NEK1 ALS